Through innovation, research, education and clinical excellence, Curaleaf International is shining a light on the possibilities of medical cannabis and is a pioneer in the global medical cannabis industry, offering high quality products.
Curaleaf International continues to expand access to innovative products worldwide with the international rollout of the QUE Medical Inhalation Device.
QUE Medical Inhalation Device, is tested under standardized conditions to assess dose uniformity, repeatability, and suitability for medical use and it is the First CE- certified Liquid Medical Cannabis Inhaler.
The device has passed the safety, performance and biocompatibility tests in line with the MDR (Regulation (EU) 2017/745 on medical devices). This patient-friendly, compact, and discreet device is designed with precision in mind, giving prescribers confidence in this controlled delivery system.
